Tumefactive multiple sclerosis and hepatitis C virus 2a/2C infection: Dual benefit of long-term interferon beta-1a therapy?

导出 LinkOut

翻译打印收藏纠错

作者： Edward C,Mader ^[1] ; Wael,Richeh ^[2] ; Joaquin Maury,Ochoa ^[3] ; Lacey L,Sullivan ^[4] ; Amparo N,Gutierrez ^[5] ; Jesus F,Lovera ^[6]

作者单位： Louisiana State University Health Sciences Center, Department of Neurology, 1542 Tulane Avenue, New Orleans, LA 70112, USA. Electronic address: emader@lsuhsc.edu. ^[1] Louisiana State University Health Sciences Center, Department of Neurology, 1542 Tulane Avenue, New Orleans, LA 70112, USA. Electronic address: wriche@lsuhsc.edu. ^[2] Louisiana State University Health Sciences Center, Department of Neurology, 1542 Tulane Avenue, New Orleans, LA 70112, USA. Electronic address: jmaury@lsuhsc.edu. ^[3] Tulane University Health Sciences, Department of Pathology and Laboratory Medicine, 1430 Tulane Avenue SL-79, New Orleans, LA 70112, USA. Electronic address: lsulliva@tulane.edu. ^[4] Louisiana State University Health Sciences Center, Department of Neurology, 1542 Tulane Avenue, New Orleans, LA 70112, USA. Electronic address: agutie@lsuhsc.edu. ^[5] Louisiana State University Health Sciences Center, Department of Neurology, 1542 Tulane Avenue, New Orleans, LA 70112, USA. Electronic address: jlover@lsuhsc.edu. ^[6]

关键词 Acute disseminated encephalomyelitis HCV genotype 2a/2c Hepatitis C virus infection Interferon beta-1a Peginterferon Tumefactive multiple sclerosis